Anaqua Integrates Big Data Analytics into Intellectual Property Management
Anaqua, Inc., a leading provider of intellectual property analytics and management software and services, today announced the availability of a major product release that embeds big data analytics into the leading IP Management platform. ANAQUA 8.6 enriches the IP process with business insight gleaned from more than 100 million patents and 1 billion related artifacts. This intelligent system uncovers fresh opportunities to drive revenue and reduce costs and risk through unique new capabilities powered by the integration of analytics from AcclaimIP, which Anaqua acquired in the spring of 2016.
As competitive organizations seek to become smarter about getting maximum business value from intellectual property at the lowest possible cost, they need insight that guides better decisions throughout the process. Historically the power of IP analytics was tapped by a select few data analysts and search specialists. ANAQUA 8.6 is the first IP management platform to infuse the entire process of creating, protecting and monetizing IP with analytics delivered to the right user, in the right format at the right time. For the first time, inventors, business executives, IP leaders, operations managers, attorneys, and paralegals can benefit from the insight delivered through a unified IP platform.
Key features in ANAQUA 8.6 include:
- My HyperViews™ - the flexibility to create and share interactive dashboards.
- Snapshot Analytics™ - pre-packaged analytics with configurable charts and visuals included in the IP Management Platform to aggregate the patent’s score based on its lifecycle.
- Smart WorkSpaces™ - deliver analytics to every stakeholder with persona-based workspaces that bring insights, content, tools and tasks together for making strategic and more informed decisions.
- Anti-counterfeit mobile app with geo-location – photograph and report on location for potentially phony products.
- Anaqua to Anaqua – an interface that allows law firms and their clients to exchange data seamlessly and securely.
“Our customers wanted more than just a product suite so we took a different approach,” said Bob Romeo, Anaqua CEO. “Big data has game-changing potential. We put the power of insight into the hands of everyone who needs it by embedding analytics into the IP workflow. This is unique and it will help our customers make better decisions.”
“Anaqua continues to lead and innovate in their latest release with a powerful toolkit to drive IP as a business – and they score big,” said Eyal Iffergan, President of Hyperion Research, the legal industry’s leading analyst-based market research firm covering the IP solutions market. “We mean that quite literally,” continued Iffergan, “as Anaqua’s new release deftly showcases recent acquisition AcclaimIP’s proprietary Patent Score technology. Demonstrating one of the fastest platform integrations we’ve ever observed, 8.6 is loaded with Patent Score indicators, engaging HyperView visualizations, and contextual analytics tightly integrated into a robust IP operations platform. Anaqua’s pragmatic, thoughtful approach to data-driven decision support is precisely what makes IP Business Management (IPBM) approachable IP.”
About Anaqua, Inc.
Anaqua helps corporations and law firms turn intellectual property into competitive advantage. Its software platform combines insight from big data analytics with critical tools, best practice workflows and services into one efficient, intelligent environment that helps IP practices work more efficiently and make better decisions faster. Many of the best-known brands and most innovative products were conceptualized, evaluated, protected and monetized through the ANAQUA platform. Founded in 2004 by IP leaders from The Coca-Cola Company, Ford Motor Company, Kimberly-Clark and British American Tobacco, Anaqua is a privately held company headquartered in Boston (U.S.) and has locations across Europe and Asia.
For additional information, please visit http://www.anaqua.com.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 19:41 | Pressemelding
Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the
ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21 | Pressemelding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li
Xilam: H1 2018 Revenue: +50%18.7.2018 16:00 | Pressemelding
Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t
Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38 | Pressemelding
The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign
Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05 | Pressemelding
Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d
Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 12:00 | Pressemelding
Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste